2,4,4,5,5-Pentamethyl-1,3,2-dioxaborolane, 95.0%, 100g

(R)-2-Amino-4-(benzyloxy)butanoic acid, 95%, 5g

Dialysis membrane Spectra/Por® Biotech CE MWCO 3500–5000, 10 mm, 1 Piece(s)

5-(4-BROMO-2-METHOXY-PHENYL)-2-METHYL-OXAZOLE, 95.0%, 500mg

2-Bromo-6-nitrotoluene, 98.0%, 25g

(2E)-1-(2,5-dichlorophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

4-(2-Fluorophenyl)piperazinyl 5-methyl-3-phenylisoxazol-4-yl ketone, 95.0%, 5g

N,N-Dimethylpiperidine-3-sulfonamide hydrochloride, 97%, 250mg

2',4'-Dichloroacetophenone>98.0%(GC)500g

Potassium carbonate, anhydrous 99.9% 250 g

3-Chloro-2,4-difluoroaniline, 97.0%, 5g

2-({[(tert-Butoxy)carbonyl]amino}methyl)pyridine-4-carboxylic acid, 98%, 100mg

SPhos Pd G3, ?98.0%, 5g